Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Reports on Catalyst Pharmaceutical Partners

Sort by

Expanding on Clinical Trials of CPP-109 in Cocaine Addiction and Pre-Clinical Studies of CPP-115 (CPRX, $1.14)

Wednesday, January 25, 2012 · 10:38 am

Read More

Initiating Coverage Based on Interest in CPP-109 for Treating Cocaine Addiction (CPRX,$1.18)

Monday, January 23, 2012 · 12:42 pm

Read More

There are 2 reports on file.

« Back to Company Reports Index